Curosurf Suspension
Product Images NDC 10122-510

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Curosurf (NDC 10122-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Curosurf 1.5 mL Vial Label (Curosurf Suspension 1)

Label for Curosurf 120 mg (poractant alfa) intratracheal suspension in a 1.5 mL single-dose vial. The label includes instructions to discard unused portion, storage directions to protect from light and refrigerate, and notes it is sterile and not for injection. Manufactured by Chiesi USA, Inc., with NDC 10122-510-01.*

FDA Label Image

Curosurf 1.5ml Carton (Curosurf Suspension 2)

Curosurf 120 mg (poractant alfa) intratracheal suspension 80 mg/mL in a 1.5 mL single-dose vial. The label states the product is for intratracheal use only, not for injection, and to discard unused portions. Manufactured by Chiesi USA, Inc., the carton contains one 1.5 mL vial and provides storage instructions and composition details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.